Skip to content
Careers
Contact us
Our Company
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Investors
Indications
Overview
Prader-Willi Syndrome
Diabetes
NASH
Other Indications
Our Approach
Peripherally-restricted CB1 Blockade
The Endocannabinoid System
CB1 Inverse Agonist/Antagonist
Our Pipeline
Overview
Patients & Families
It’s all about life™
Resources (Canada/US)
News & Events
FR
EN
Menu
Home
Our Company
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Investors
Indications
Overview
Prader-Willi Syndrome
Diabetes
NASH
Other Indications
Our Approach
Peripherally-restricted CB1 Blockade
The Endocannabinoid System
CB1 Inverse Agonist/Antagonist
Our Pipeline
Overview
Patients & Families
It’s all about life™
Resources (Canada/US)
News & Events
Careers
Contact us
News
& Events
News
& Events
Latest
releases
2019
2018
2017
2016
2015
National Institutes of Health Notice on Prospective Grant of Exclusive License.
